LEXX (Lexaria Bioscience Corp. Common Stock) Stock Analysis - SEC Filings

Lexaria Bioscience Corp. Common Stock (LEXX) is a publicly traded Healthcare sector company. As of May 19, 2026, LEXX trades at $0.57 with a market cap of $14.68M and a P/E ratio of 0.00. LEXX moved -0.07% today. Year to date, LEXX is -14.36%; over the trailing twelve months it is -44.54%. Its 52-week range spans $0.46 to $3.39. Rallies surfaces LEXX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find LEXX SEC filings?

Rallies organizes LEXX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

LEXX Key Metrics

Key financial metrics for LEXX
MetricValue
Price$0.57
Market Cap$14.68M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$3.39
52-Week Low$0.46
Volume38.50K
Avg Volume0
Revenue (TTM)$705.92K
Net Income$-11.91M
Gross Margin99.61%

Latest LEXX News

Recent LEXX Insider Trades

  • BUNKA CHRISTOPHER bought 11.90K (~$10.87K) on Jul 30, 2025.
  • BUNKA CHRISTOPHER bought 15.60K (~$14.38K) on Jul 29, 2025.
  • McKechnie William Edward bought 5.00K (~$4.53K) on Jul 29, 2025.

LEXX Analyst Consensus

LEXX analyst coverage data. Average price target: $0.00.

Common questions about LEXX

Where can I find LEXX SEC filings?
Rallies organizes LEXX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show LEXX 10-K and 10-Q filings?
Rallies organizes LEXX SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is LEXX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for LEXX. It does not provide personalized investment advice.
LEXX

LEXX